FDA Reverses Order to Stop Making Liquid Morphine
A decision by the FDA will allow the painkiller to stay on the market until a replacement painkiller is approved.
Wired PR News – The Food and Drug Administration (FDA) has reversed last week’s order to stop the manufacturing of liquid morphine. As reported by the Associated Press (AP), the FDA stated that the painkiller will stay on the market until a substitute is approved.
Liquid morphine was one of 14 medications the agency was planning to order manufacturers to stop making, all of which had never been approved by the FDA.
As noted in the report, many pain relief and hospice care experts were happy about the decision due to the relief liquid morphine provides to patients who are dying or in extreme pain. Dr. Porter Story with the American Academy of Hospice and Palliative Medicine is quoted by the AP as stating the FDA decision is “a really important step in the right direction” that demonstrates, “an amazing level of responsiveness we’re not used to seeing in our government officials.”
Tags: doctor, expert, FDA, Hospice, liquid morphine, medication, morphine, palliative careOnline Health & Fitness News Press Release Distribution - WiredPRNews.com
- FREE Local Childhood Obesity Prevention Program Changes Kids Lives
- New Classification System for Air Filters Homes in on Efficiency, Savings
- Soprano Laser Hair Removal Now More Effective then IPL
- ‘New Year, New You’ Already in Jeopardy, As Brits Quit The Gym!
- Sustainability in the Workplace: Healthier Air, Higher Morale
- High Dose Rate Electronic Radiation Skin Cancer Treatment Now Available in US
- Chicago’s Gold Coast Goes Green As Skin Care Line Opens Flagship Sales Office
- Free Exercise Manual Aims to Reduce Childhood Obesity
- No Texting While Paddling: SUP Eco Adventures Provides THE Alternative
- Sandusky Accusers Get Foundation’s Help
